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Abstract 
Introduction: Sudden cardiac death (SCD) is the leading medical 
cause of death for male athletes, especially in anaerobic-based 
sports. Standard 12-lead electrocardiograms (STD-ECG) have 
received recent attention for their diagnostic utility, but lack the 
practicality for mass screenings. The purpose of this investigation 
was to assess the validity of a compact HD-EKG unit during 
various testing environments: rest, aerobic activity, and immediate 
recovery of anaerobic activity in college-age, male athletes. 
Methods: Twelve college-aged (19.9 ± 1.1 years old), male 
athletes volunteered. Test procedures included two ECG devices, 
a STD-ECG and a high-definition (HD-) EKG, simultaneously 
recording heart rate (HR) and rhythms during rest, a single-stage 
walking test, and during recovery of the Wingate Anaerobic 
Power test. 
Results: Paired t-tests did not detect differences between 
measures of HR and rhythm (t(47) = -0.71, p > 0.05 and t(4) = 
0.82, p > 0.05, respectively). The two measures of HR were very 
strongly related (r = 0.98, p < 0.001). However, the absolute 
difference between the STD-ECG and HD-EKG averaged 3.47 
± 4.44 bpm, which is significantly different than the acceptable 
variance of ± 2 bpm. 
Conclusions: Wearable technology, such as a portable HD-EKG 
device worn during vigorous anaerobic activity, such as the 
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Introduction 
There are approximately 100-150 deaths during sports activities in the United States 
annually.1 While the most common causes of sudden death in athletes are 
nonmedical or traumatic cases, sudden cardiac death (SCD) is the leading medical 
cause of death,2 with an estimated rate of 1:50,000 collegiate athletes per year.3 
Researchers have established that there is a transient, increased risk of arrhythmia-
based sudden death associated with vigorous exertion.3 In an effort to reduce SCD 
incidence in sport, the American Heart Association (AHA) developed a competitive 
athlete pre-screening tool to follow during the annual preparticipation physical exam 
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(PPE).4 If an abnormality is noted during the PPE, the examiner may recommend 
that the athlete receive an electrocardiogram (ECG), echocardiogram, stress test, or 
other follow-up diagnostic testing.4   
  
Although recommendations for the pre-screening of athletes are in place, from 2003-
2013, SCD accounted for 79 of the 514 total student athlete deaths (1:53,705), with 
male athletes accounting for 81% of SCDs.5 Further breakdown of factors impacting 
SCD revealed 72 of the 79 deaths occurred with exertion, and the majority of SCD 
occurred in basketball, football, and men’s soccer, respectively.5 To date, there is no 
consensus on the most effective and efficient screening tool to identify underlying 
cardiovascular conditions in young athletes. 
  
A few investigators have attempted to identify heart rate variability (HRV) as an 
indicator of abnormal cardiac function.6,7 However, there have been limited studies 
using wearable technology and HRV to evaluate cardiac function in athletes.6–8 In a 
comparison of amateur athletes and sedentary subjects, a portable monitor 
(BioHarness 3.0) enabled comparisons of ECG tracings, heart rate (HR) and HRV 
during rest, aerobic exercise, and recovery.8 However, the response of the athletic 
heart to anaerobic exercise, simulating a sudden burst of vigorous exertion, has not 
been evaluated.   
  
In the current study, a portable, compact, 2-lead high-definition electrocardiogram 
device (HD-EKG) was tested on athletes to wirelessly monitor the electrical activity 
of the heart in real time. Evaluation of HR, short-term HRV, and rhythm in aerobic 
and anaerobic conditions may provide more insight in identifying cardiovascular 
conditions in athletes. Therefore, the purpose of this investigation is to assess the 
validity of a HD-EKG unit during various testing environments: rest, aerobic 
activity, and immediate recovery of anaerobic activity in college-age, male athletes. 
The researchers hypothesize that there will be no difference between the HD-EKG 




Thirteen college-aged male athletes from a small university in Wisconsin volunteered 
to participate in this study during their off-season. Participants completed a pre-
participation medical history questionnaire. Researchers excluded participants if they 
had any known cardiovascular, respiratory, metabolic, or musculoskeletal conditions 
that may affect physiological responses to exercise testing. All participants completed 
an Institutional Review Board approved written liability waiver and informed 
consent, indicating their voluntary participation in the study. 
 
Protocol 
Five days prior to the first scheduled testing session, participants attended an 
orientation session where they received instruction on completing questionnaires to 
document their physical activity, dietary intake, and sleep quality during the 72-hours 
before testing. Participants received verbal and written pre-test instructions related 
to exercise clothing, as well as avoiding exertion the day of testing.9  Instructions also 
included refraining from ingesting food or drink containing caffeine, alcohol, or 
other stimulants that may affect HR, blood pressure, or heart rhythm at least 3 hours 
prior to scheduled testing.9 
 
All testing was performed in an environmentally-controlled university exercise 
physiology laboratory and followed the American College of Sports Medicine 
procedures for fitness testing.9 Researchers collected baseline resting HR and blood 
pressure measurements after 5-minutes of seated rest, in accordance with AHA 
guidelines.10 The researchers also collected anthropometric data, including height (m) 
and weight (kg) using a Health o meter® (McCook, IL) balance beam scale with 
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stadiometer. The researchers assessed body composition following standardized 
procedures for waist circumference using a Gulick (Creative Health Products, Ann 
Arbor, MI) tape measure, and percent body fat using the skinfold technique with 
Lange (Beta Technology, Santa Cruz, CA) calipers and the Jackson-Pollock 3-site 
formula for men.11,12 
  
Prior to exercise testing, each participant completed a resting ECG, using both the 
STD-ECG and HD-EKG. To reduce variability in trace quality due to differences in 
skin preparation, as well as electrode placement technique and methodology, the 
same researcher performed all resting ECGs. The ECGs were recorded in the supine 
position during the last 30-seconds of the 5-minute rest period. For the STD-ECG, 
standard skin preparation included the researcher removing any excess body hair as 
needed, cleansing with an alcohol swab, drying, and lightly abrading the skin at the 
electrode placement sites with 3M™ Red Dot Trace Prep (St. Paul, MN).13 The STD-
ECG was recorded using the Cardiac Science CareCenter MD wireless ECG 
monitoring device (Bothellm, WA) with disposable, diagnostic ECG skin electrodes 
and the modified Mason-Likar 12-lead electrode placement.14 Following the set-up 
of the STD-ECG, the HD-EKG electrode sensors were dampened, and the device 
was secured to the participant using a chest strap placed directly below the precordial 
leads, V3 and V4, as displayed in Figure 1. The 2-lead HD-EKG signals, which 
correspond to lead I and V3 of a STD-ECG,13 was synced with the Applied 
Advanced Technologies (Milwaukee, WI) application. After the resting ECGs were  
acquired and HR was recorded, the participant stood up and walked a short distance 
so the researchers could determine if any electrodes needed to be adjusted and then 
applied a stretchable net stress vest. Researchers explained that test procedures 
would include performing a Ebbeling single-stage treadmill walking test (SSWT) as a 
warm-up for the Wingate anaerobic power test (WAP).15  Measurements of HR, 
blood pressure, oxygen saturation and rate of perceived exercise would be obtained 
at the end of each phase of testing, and symptoms of abnormal responses to exercise 
would be continuously monitored.9 Set-up concluded with a researcher escorting the 
participant to the Monark Ergomedic 894 E Peak cycle ergometer (Vansbro, 
Sweden) to adjust seat height to accommodate stature, such that the participant’s 
knee would be slightly flexed (approximately 25 degrees) at maximal leg extension, 
and to adjust the handlebar based on participant’s comfort.9  
 
Next, the participant was guided to the Woodway Desmo treadmill (Waukesha, WI) 
to complete the SSWT as a submaximal warm-up. The researchers followed the 
Ebbeling SSWT procedures, adjusting the treadmill speed within the first minute to 
allow the participant to achieve an exercise HR equivalent to approximately 60% 
HRmax at the conclusion of the test.15  Although HR and rhythm were continuously 
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monitored, only during the last 30 seconds of this phase did the two ECG devices 
record tracings. During the 4-minute exercise stage, the treadmill speed remained 
constant, and the grade was increased to 5%.15 To ensure a steady state HR during 
the last two minutes of the exercise stage, researchers collected HR at each minute 
with the STD-ECG.15  Similar to the warm-up phase, STD-ECG and HD-EKG 
tracings were recorded during the last 30 seconds. 
  
Upon completion of the SSWT, the participant was immediately transferred to the 
previously set up cycle ergometer to complete the WAP.  Participants completed a 
1-minute warm-up, pedaling at a self-selected moderate-to-vigorous pace against no 
resistance. Researchers then instructed the participants to pedal at full speed with the 
cycle ergometer unloaded. Once full pedal speed was achieved (5-8s), the researchers 
immediately counted down to the start of the test, applying the calculated workload 
(0.075 kg per kg of body weight) for 30 seconds.16 Throughout the WAP, researchers 
verbally encouraged the participant. Immediately upon test completion, the 
participant started active recovery pedaling at a self-selected light pace with no 
resistance, while the researchers collected 6-second rhythm strips with the STD-
ECG and HD-EKG at 30-seconds and 60-seconds post WAP. The researchers 
terminated recovery when the participant’s HR returned to pre-exercise values or 
below 100 bpm. 
 
Statistical Analysis 
Data from participants (n=12) who completed all testing components were analyzed. 
To assess the validity of the HD-EKG, the researchers conducted a paired samples 
t-test between STD-ECG and HD-EKG HR and rhythm recordings and conducted 
a Pearson correlation for each of the conditions (rest, SSWT, immediately post-
WAP, and recovery). To reflect clinical practice in measuring, the researchers set the 
acceptable absolute difference between measures to two bpm. The researchers 
calculated an absolute difference score to determine the range of variability between 
measures and conducted a one-sample t-test with the criterion value of two. Bland-
Altman17 and line of best fit plots presented graphical of data. The researchers 
assessed data using SPSS 25.0 (IBM, Chicago, IL) with statistical significance set to p 
< 0.05 a priori.  
 
Results  
Table 1 presents participants demographic and anthropometric data. Table 2 depicts 
the mean, standard deviation, and 95% confidence interval for both HR measures 
during the four conditions. The two measures were not significantly different for HR 
(t(47) = - 0.71, p > 0.05) or frequency of abnormal heart rhythms (Table 3; t(4) = 
0.82, p > 0.05). Absolute differences (3.47 ± 4.44bpm) were significantly different 
compared to the standard acceptable difference score of 2 bpm (t(59) =  0.255, p = 
0.01). However, 12% of recordings had a difference score of 0 (7/60), while 60% 
had a difference score of ≤ 2 bpm (36/60). The two measures of HR were very 
strongly related (r = 0.98, p < 0.001) specifically during rest, immediate post-WAP, 
and recovery (r=0.89, p < 0.001; r = 0.75, p = 0.005; r = 0.67, p = 0.02; respectively), 
as supported by the line of best fit and Bland-Altman plots (Figure 2). The two 
measures of HR were not related for the SSWT (r = 0.02, p > 0.05).  
 
Table 1. Participant (n = 12) baseline and anthropometric data 
Variables Mean SD 
Age (y) 19.9 1.1 
Height (m) 1.7 0.5 
Weight (kg) 79.7 8.8 
Body mass index (kg/m²) 26.5 2.8 
Percent body fat 10.5 3.5 
Resting HR (bpm) 66.5 5.3 
Resting Systolic BP 121.8 7.8 
Resting Diastolic BP 69.3 6.6 
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Table 2. Heart rate values as assessed by a standard and high-definition 
electrocardiograms. 
 
  Standard High-definition 
 Mean     (SD) [95% CI] Mean      (SD) [95% CI] 
Rest  64.08   (4.12) [  62.11,   66.97]  64.33    (5.71)  [  62.37,   69.21] 
Single stage walk test 117.83   (3.24) [115.77, 119.89] 118.92    (5.92) [115.16, 122.68] 
Immediate post-WAP  131.00   (8.41) [125.66, 136.34] 130.92   (10.46) [124.27, 131.24] 
Recovery  108.08   (3.11) [106.10, 110.06] 108.92    (4.32) [106.17, 111.66] 
CI – confidence interval; WAP = Wingate anaerobic power test 
 
Table 3. Rhythm analysis between standard and high-definition electrocardiograms 
 Standard  High-definition 
Normal sinus rhythm 1 1 
Sinus bradycardia 3 4 
LVH 7 0 
LAE 8 8 







The purpose of the current investigation was to evaluate the validity of a portable, 
compact HD-EKG unit compared to a STD-ECG in evaluating HR, short-term 
HRV, and heart rhythms under various testing environments: rest, aerobic activity, 
and immediate recovery of anaerobic activity in college-age, male athletes. To our 
knowledge this is the first study to evaluate wearable technology compared to a STD-
ECG under anaerobic testing conditions to simulate a sudden burst of vigorous 
physical activity associated with anaerobic sports, such as basketball, which have a 
higher incidence of SCD.5  In the present study, the measured HR values and 
rhythms obtained from the tracings between the HD-EKG and STD-ECG were not 
different. 
  
Our primary findings for the HD-EKG are consistent with previous studies 
reporting a strong correlation between the ECG and more recent HR monitors, using 
chest electrodes, in assessing the RR interval to determine HR.18–20 As a practitioner, 
an acceptable range for accuracy in manually measuring resting HR using radial 
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pulses is ±2 bpm.21  Our results fall within this range 60% of the time. If the 
acceptable difference was broadened to ±3 bpm as demonstrated in recording radial 
pulses of using different time durations from 6 to 30 seconds,21 72% of our measures 
would fall within that range. Furthermore, our data were collected during moderate-
to-vigorous physical activities, which increases the HR variance due to errors 
associated with increased artifact (noise) with increasing exercise intensity. 
  
In addition to detecting the RR interval for HR measurement, the HD-EKG also 
has the capacity to monitor heart rhythms to potentially detect arrhythmias.  The 
focus of the Applied Advanced Technologies application was the detection of atrial 
fibrillation (Afib), which is a common arrhythmia in athletes.22  Due to the 
association between left atrial enlargement and Afib,23 left atrial enlargement was 
evaluated as well as other common arrhythmic conditions found in individuals who 
regularly participate in exercise due to physiological, functional or structural 
adaptations of the heart, commonly known as “Athlete's Heart”.24 With the 
exception of left ventricular hypertrophy (LVH), there was no difference between 
the two devices in detecting the frequency of abnormal heart rhythms (Table 4).  One 
explanation for the inability of the HD-EKG to capture LVH is that this arrhythmia 
is most evident in leads V1, V2, V5 and V6;25 whereas, the HD-EKG device 
monitored leads I and V3. 
  
Limitations of this study include a small sample size, and the results can only be 
applied to apparently healthy, active males.  Due to missing data for HRV, the utility 
of the HD-EKG as a valid tool for determining HRV could not be evaluated.  In 
addition, the HD-EKG did not detect LVH, which may have resulted from electrode 
placement. While LVH is a physiological adaptation to training, it is not always a 
protective adaptation.6 Future studies on chest strap placement are 
warranted.  Furthermore, the participants in this study did not present with any 
uncommon, non-training related ECG changes that would require further medical 
evaluation. 
   
Based on the results of this investigation, the HD-EKG is a valid tool for the 
detection of RR intervals for HR measurement as well as the identification of 
common abnormal heart rhythms under rest, aerobic activity, and immediate 
recovery of anaerobic activity in college-age, male athletes. Compared to other 
portable devices, a standard HR monitor cannot provide the depth of information 
as the HD-EKG, and the STD-ECG is not practical in a field setting due to lead 
wires that could fall off, damage to the device, or potential injury in contact 
sports.  While many of the emerging wearable ECG devices focus on monitoring for 
older adults and individuals with known chronic conditions,20 the HD-EKG may fit 
the need for a valid low-cost, practical screening tool to accurately assess HR and 
rhythm during sports activities and recovery.  The HD-EKG may allow for the early 
detection and monitoring of arrhythmic conditions, which may be associated with 
SCD in sports participants. 
 
Media-Friendly Summary 
While a rare event in sports, sudden cardiac death in young athletes is a tragedy that 
has growing awareness from the public, as well as the sports medicine 
field.  Currently, the standard preparticipation screening tool is ineffective in 
correctly detecting and interpreting heart abnormalities in this population, and 
clinical testing may not be feasible for all athletes in the United States.  However, 
with new wearable technology, monitoring both heart rate and rhythms during 
physical activity, particularly high intensity aerobic and anaerobic activities, may be 
more practical and provide greater insight into those athletes who are at greater risk 
of experiencing a cardiac incident, thereby reducing the rate of sudden cardiac death. 
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